HomeProductsBioactive CompoundsAnti-Infective AgentsHIV ProteaseAtazanavir
Chemical structure of CAS 198904-31-3

Atazanavir

In Stock•Starting at $8 for 10 mg•Purity ≥ 95%
CAS No.198904-31-3
MDL No.MFCD08435966
MFC38H52N6O7
MW704.90
InChI KeyAXRYRYVKAWYZBR-GASGPIRDSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg95%$8In Stock
50 mg95%$11In Stock
100 mg95%$16In Stock
250 mg98%$19In Stock
1 g98%$35In Stock
5 g98%$67In Stock
25 g98%$174In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Atazanavir is a heavily substituted carbohydrazide and an antiretroviral drug of the protease inhibitor (PI) class used to treat human immunodeficiency virus (HIV) infection. It functions as an antiviral drug and HIV protease inhibitor.

CAS No.198904-31-3
Product NameAtazanavir

Associated Conditions

viral disease·infection·HIV-1 infection·HIV infection·AIDS·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.

The Journal of the Association of Nurses in AIDS Care : JANAC • Vol. 13, Issue 2 • 2002
PMID: 11936070DOI: 10.1016/s1055-3290(06)60208-2

[New HIV-1 protease inhibitors in development].

Nihon rinsho. Japanese journal of clinical medicine • Vol. 60, Issue 4 • 2002
PMID: 11968788

[Improving resistance profile, simplifying administration mode. New antiretroviral drugs].

MMW Fortschritte der Medizin • Vol. 144 Suppl 1 • 2002
PMID: 12043080

In vitro antiviral interaction of lopinavir with other protease inhibitors.

Antimicrobial agents and chemotherapy • Vol. 46, Issue 7 • 2002
PMID: 12069982PMC: PMC127306DOI: 10.1128/AAC.46.7.2249-2253.2002

Documentation

Similar Products